|Rapid review complete
|Indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Evaluation Recommended at the Submitted Price
The HSE has approved reimbursement following confidential price negotiations November 2017.